ALS Canada and ALS Quebec co-host the international ALS/MND community in Montreal

June 21, 2024 – Today, in recognition of Global ALS Awareness Day, the ALS Society of Canada (ALS Canada) and the ALS Society of Quebec (ALS Quebec) are proud to announce their partnership to co-host a series of international meetings dedicated to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and motor neuron disease (MND). The series will begin with the International Alliance of ALS/MND Associations Annual Meeting, followed by the Allied Professionals Forum, culminating with the 35th International Symposium on ALS/MND this December in Montreal, Quebec.

These annual meetings unite stakeholders from across the global ALS ecosystem to address the issues facing people affected by ALS today and to create a future for a world free of ALS/MND. They provide a platform to share initiatives happening around the world and will offer an opportunity to highlight the contributions of researchers, health professionals, and ALS organizations in Canada.

The International Alliance of ALS/MND Associations Annual Meeting will take place on December 2-3. This meeting aims to share insights and strengthen collaborative efforts to address the needs of people affected by ALS.

The Allied Professionals Forum will be held from December 4-5 and will gather a diverse range of health care professionals for knowledge exchange and to learn about advancements in ALS/MND care.

The Allied Professional Forum and Alliance Meeting will convene more than 500 delegates from 40+ countries both virtually and in person.

Finally, from December 6-8, the International Symposium on ALS/MND, the largest medical and scientific conference dedicated to ALS/MND research, will bring together more than 1,200 delegates from around the world, including researchers, clinicians, allied health professionals, industry, people living with ALS and their loved ones, to discuss and share the latest advances in research, care, and treatment.

The symposium will feature a diverse program that includes basic and clinical science, therapy development, and clinical management. Delegates will have the chance to showcase their research through poster exhibitions and presentations.

Meetings are in person and virtual. For more information and to register, visit https://symposium.mndassociation.org/.

ALS Canada

“ALS Canada is honoured to co-host these important international meetings in Montreal this December alongside our partners at ALS Quebec. This provides an invaluable opportunity for the world’s leading researchers, health care professionals, and people affected by ALS to come together to share ideas, spark future collaboration, and potentially the next breakthrough,” says Tammy Moore, CEO of the ALS Society of Canada. “By fostering these global connections and sharing the latest advancements in research and care, we move closer to our shared goal of a world free of ALS.”

ALS Quebec

“ALS Quebec is thrilled to welcome the global ALS/MND community to Montreal, a city renowned for its vibrant culture and collaborative spirit,” says Claudine Cook, Executive Director of ALS Quebec. “Alongside our co-host ALS Canada, we’re looking forward to the energy and commitment of delegates around the world whose personal and professional knowledge and experiences will inspire continued action and change in creating a brighter future for all affected by ALS/MND.”

International Alliance of ALS/MND Associations

“For the Alliance, we see the ALS/MND research and care as a global endeavour. This disease transcends borders, and we can learn a lot from how professionals in other countries are handling issues and how care is provided,” says Cathy Cummings, CEO of the International Alliance of ALS/MND Associations. “To think more broadly, we need international collaboration among all the people affected: our members, researchers, service providers and people living with ALS/MND. This is what our conferences provide. Participants leave with new connections and motivation to do more to win the fight against ALS/MND.”